Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
619.50    -0.50 (-0.08%)
Bid:
619.00
Ask:
620.00
Spread: 1.00 (0.162%)
Market Cap: £2.86b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

AGM Update

11 Jul 2024 07:00

RNS Number : 9276V
RS Group PLC
11 July 2024
 

 

11 July 2024, 7.00 am

 

RS GROUP PLC

 

AGM update

 

RS Group plc, the global distributor of maintenance, repair and operation products and service solutions to industrial customers, provides the following trading update for the three months ended 30 June 2024, ahead of its Annual General Meeting to be held at 12.00 pm today.

Trading in the first quarter was in line with expectations. Group revenue grew 3% over the same period in the prior year and declined by 3% on a like-for-like basis, excluding acquisitions, foreign currency and trading days.

As trading conditions stabilise and comparatives get easier, the pace of decline in like-for-like revenue across all three regions continues to slow as anticipated. In EMEA, like-for-like revenue declined 3% reflecting largely ongoing volatility in various PMIs1 across the region, although total revenue grew by 7% with an additional quarter's contribution from Distrelec. Like-for-like revenue in Americas benefitted from a strong performance from Risoul but declined by 3% due to continuing weakness in electronics and industrial automation markets. Similarly, Asia Pacific continues to be impacted by weakness in electronics with like-for-like revenue down by 3% but is beginning to demonstrate underlying improvement.

We are progressing well with our cost savings programme, the integration of our acquisitions, and investment in operational efficiencies and system enhancements. We remain confident this multiyear investment will improve future operating leverage and returns.

Investor Event: 24 September 2024

We look forward to hosting our Investor Event on 24 September 2024 in London to outline our investment proposition and strategic action plan to generate sustainable through-cycle growth and returns.

 

Notes:

1. Purchasing manager index (PMI) is a survey-based economic indicator designed to provide a timely insight into business conditions. The PMI is widely used to anticipate changing economic trends in official data such as GDP, or sometimes as an alternative gauge of economic performance and business conditions to official data, as the latter sometimes suffer from delays in publication, poor availability or data quality issues (Source: S&P Global).

2. Consensus estimates for the year ended 31 March 2025 is revenue of £3,019 million, adjusted operating profit of £307 million and adjusted profit before tax of £274 million. Source: rsgroup.com/investors/analyst-consensus/.

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2024 for euro and US dollar respectively were €1.159 and $1.257 respectively. Every 1 cent movement in the euro has a c. £2.0 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.7 million impact on annual adjusted profit before tax.  

4. We expect to see a positive impact of around £29 million on revenue from greater trading days in 2024/25 compared to 2023/24.  

 

Enquiries:

Kate Ringrose

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Teneo Communications

020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFQKKBNPBKDBOD
Date   Source Headline
3rd Jul 20238:00 amRNSCompletion of Distrelec Acquisition
30th Jun 202312:09 pmRNSNotice of Trading Update
20th Jun 202312:00 pmRNSDirector/PDMR Shareholding
15th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20239:00 amRNSHolding(s) in Company
7th Jun 202312:00 pmRNSAnnual Financial Report
1st Jun 20239:25 amRNSTotal Voting Rights
30th May 202312:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
26th May 202310:00 amRNSDirector/PDMR Shareholding
24th May 20238:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSFinal Results
15th May 202310:00 amRNSBoard Committee Change
3rd May 20237:00 amRNSDirectorate Change
2nd May 202310:00 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSAcquisition
13th Apr 20233:43 pmRNSHolding(s) in Company
5th Apr 20237:00 amRNSQ4 Trading Statement
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20239:00 amRNSChange of Auditor
21st Mar 20239:00 amRNSBlock Listing Application
17th Mar 20234:08 pmRNSNotice of Trading Update: Change of Date
14th Mar 20231:42 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSAppointment of Simon Pryce as CEO
9th Mar 20238:00 amRNSNotice of Trading Update
1st Mar 202312:19 pmRNSTotal Voting Rights
10th Feb 20234:20 pmRNSHolding(s) in Company
1st Feb 20238:51 amRNSBlock listing Interim Review
1st Feb 20238:45 amRNSTotal Voting Rights
26th Jan 20233:00 pmRNSAdditional Listing
13th Jan 20239:00 amRNS2022 AGM Vote Outcome Update Statement
10th Jan 20237:00 amRNSTrading Statement
9th Jan 20234:30 pmRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSCompletion of Risoul Acquisition
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 20229:13 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSDirectorate Change
1st Dec 20224:54 pmRNSTotal Voting Rights
7th Nov 20227:13 amRNSDirector Declaration
3rd Nov 20227:01 amRNSHalf-year Report
3rd Nov 20227:00 amRNSCEO Leave of Absence
1st Nov 202210:54 amRNSTotal Voting Rights
6th Oct 20227:00 amRNSTrading Statement
3rd Oct 202211:00 amRNSTotal Voting Rights
28th Sep 20221:41 pmRNSNotice of Trading Update
21st Sep 202211:00 amRNSHolding(s) in Company
1st Sep 20224:02 pmRNSAppointment of Joint Corporate Broker
1st Sep 202212:05 pmRNSTotal Voting Rights
17th Aug 202211:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.